Loading…

Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma

Abstract Background In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable mult...

Full description

Saved in:
Bibliographic Details
Published in:Gastroenterology report 2024-07, Vol.12, p.goae060
Main Authors: Shin, Young Seob, Jang, Jeong Yun, Yoo, Ye Jin, Yu, Jesang, Song, Kye Jin, Jo, Yoon Young, Kim, Sung-Bae, Park, Sook Ryun, Song, Ho June, Kim, Yong-Hee, Kim, Hyeong Ryul, Kim, Jong Hoon
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083
container_end_page
container_issue
container_start_page goae060
container_title Gastroenterology report
container_volume 12
creator Shin, Young Seob
Jang, Jeong Yun
Yoo, Ye Jin
Yu, Jesang
Song, Kye Jin
Jo, Yoon Young
Kim, Sung-Bae
Park, Sook Ryun
Song, Ho June
Kim, Yong-Hee
Kim, Hyeong Ryul
Kim, Jong Hoon
description Abstract Background In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable multiparameter nomogram model that combines tumor characteristics, imaging modalities, and hematologic markers to predict pCR in patients with ESCC who underwent PCRT and esophagectomy. Methods We retrospectively reviewed the medical records of 457 patients with ESCC who received PCRT followed by esophagectomy between January 2005 and October 2020. The nomogram model was developed using logistic regression analysis with a training cohort and externally validated with a validation cohort. Results In the training and validation cohorts, 44.2% (126/285) and 48.3% (83/172) of patients, respectively, achieved pCR after PCRT. The 5-year rates of overall survival, progression-free survival, and freedom from local progression in the training cohort were 51.6%, 48.5%, and 77.6%, respectively. The parameters included in the nomogram were histologic grade, clinical N stage, maximum standardized uptake value on positron emission tomography, and post-PCRT biopsy. Hematologic markers were significantly associated with survival outcomes but not with pCR. The area under the receiver operating characteristic curve of the nomogram was 0.717, 0.704, and 0.707 for the training cohort, internal validation cohort, and external validation cohort, respectively. Conclusion Our nomogram model based on four parameters obtained from standard clinical practice demonstrated good performance in both the training and validation cohorts and could be useful to aid clinical decision-making to determine whether surgery or active surveillance strategy should be pursued.
doi_str_mv 10.1093/gastro/goae060
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11227365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/gastro/goae060</oup_id><sourcerecordid>3076765078</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhiMEolXplSPyEQ7bjuM4zp4QqgpFquDSni3HmSRGcca1nVZ9DN6YbHepyomTLfvzNzP-i-I9hzMOW3E-mJQjnQ9kEGp4VRyXIMsNgKhev9gfFacp_QIADqqUXL4tjkSzVVWjmuPi9w_yNETjWU-RhYids9nNAwsmjzTR4Cyz5MOEGVnEFGhOuLLTRA9PWEQKGE1298jsiJ6i6RzlcT0Lj8zNO5HDOSf24PLIMFEYzYBmYuluMZ6WxCxOE7MmWjeTN--KN72ZEp4e1pPi9uvlzcXV5vrnt-8XX643VnDIm2proa5AQtdvq66VohRVj0q1reKK903fWdvKGhD6UoBVFQrVy1ryjsv1LxpxUnzee8PSeuzs2mM0kw7ReRMfNRmn_72Z3agHutecl6UStVwNHw-GSHcLpqy9S7thzIzrXFqAqlUtQe2Kne1RGymliP1zHQ56l6XeZ6kPWa4PPrzs7hn_m9wKfNoDtIT_yf4AO8Gwzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3076765078</pqid></control><display><type>article</type><title>Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma</title><source>Open Access: PubMed Central</source><source>Open Access: Oxford University Press Open Journals</source><creator>Shin, Young Seob ; Jang, Jeong Yun ; Yoo, Ye Jin ; Yu, Jesang ; Song, Kye Jin ; Jo, Yoon Young ; Kim, Sung-Bae ; Park, Sook Ryun ; Song, Ho June ; Kim, Yong-Hee ; Kim, Hyeong Ryul ; Kim, Jong Hoon</creator><creatorcontrib>Shin, Young Seob ; Jang, Jeong Yun ; Yoo, Ye Jin ; Yu, Jesang ; Song, Kye Jin ; Jo, Yoon Young ; Kim, Sung-Bae ; Park, Sook Ryun ; Song, Ho June ; Kim, Yong-Hee ; Kim, Hyeong Ryul ; Kim, Jong Hoon</creatorcontrib><description>Abstract Background In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable multiparameter nomogram model that combines tumor characteristics, imaging modalities, and hematologic markers to predict pCR in patients with ESCC who underwent PCRT and esophagectomy. Methods We retrospectively reviewed the medical records of 457 patients with ESCC who received PCRT followed by esophagectomy between January 2005 and October 2020. The nomogram model was developed using logistic regression analysis with a training cohort and externally validated with a validation cohort. Results In the training and validation cohorts, 44.2% (126/285) and 48.3% (83/172) of patients, respectively, achieved pCR after PCRT. The 5-year rates of overall survival, progression-free survival, and freedom from local progression in the training cohort were 51.6%, 48.5%, and 77.6%, respectively. The parameters included in the nomogram were histologic grade, clinical N stage, maximum standardized uptake value on positron emission tomography, and post-PCRT biopsy. Hematologic markers were significantly associated with survival outcomes but not with pCR. The area under the receiver operating characteristic curve of the nomogram was 0.717, 0.704, and 0.707 for the training cohort, internal validation cohort, and external validation cohort, respectively. Conclusion Our nomogram model based on four parameters obtained from standard clinical practice demonstrated good performance in both the training and validation cohorts and could be useful to aid clinical decision-making to determine whether surgery or active surveillance strategy should be pursued.</description><identifier>ISSN: 2052-0034</identifier><identifier>EISSN: 2052-0034</identifier><identifier>DOI: 10.1093/gastro/goae060</identifier><identifier>PMID: 38974878</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Original</subject><ispartof>Gastroenterology report, 2024-07, Vol.12, p.goae060</ispartof><rights>The Author(s) 2024. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083</cites><orcidid>0000-0002-5544-9492 ; 0000-0003-2177-4876</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227365/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11227365/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,1604,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38974878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shin, Young Seob</creatorcontrib><creatorcontrib>Jang, Jeong Yun</creatorcontrib><creatorcontrib>Yoo, Ye Jin</creatorcontrib><creatorcontrib>Yu, Jesang</creatorcontrib><creatorcontrib>Song, Kye Jin</creatorcontrib><creatorcontrib>Jo, Yoon Young</creatorcontrib><creatorcontrib>Kim, Sung-Bae</creatorcontrib><creatorcontrib>Park, Sook Ryun</creatorcontrib><creatorcontrib>Song, Ho June</creatorcontrib><creatorcontrib>Kim, Yong-Hee</creatorcontrib><creatorcontrib>Kim, Hyeong Ryul</creatorcontrib><creatorcontrib>Kim, Jong Hoon</creatorcontrib><title>Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma</title><title>Gastroenterology report</title><addtitle>Gastroenterol Rep (Oxf)</addtitle><description>Abstract Background In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable multiparameter nomogram model that combines tumor characteristics, imaging modalities, and hematologic markers to predict pCR in patients with ESCC who underwent PCRT and esophagectomy. Methods We retrospectively reviewed the medical records of 457 patients with ESCC who received PCRT followed by esophagectomy between January 2005 and October 2020. The nomogram model was developed using logistic regression analysis with a training cohort and externally validated with a validation cohort. Results In the training and validation cohorts, 44.2% (126/285) and 48.3% (83/172) of patients, respectively, achieved pCR after PCRT. The 5-year rates of overall survival, progression-free survival, and freedom from local progression in the training cohort were 51.6%, 48.5%, and 77.6%, respectively. The parameters included in the nomogram were histologic grade, clinical N stage, maximum standardized uptake value on positron emission tomography, and post-PCRT biopsy. Hematologic markers were significantly associated with survival outcomes but not with pCR. The area under the receiver operating characteristic curve of the nomogram was 0.717, 0.704, and 0.707 for the training cohort, internal validation cohort, and external validation cohort, respectively. Conclusion Our nomogram model based on four parameters obtained from standard clinical practice demonstrated good performance in both the training and validation cohorts and could be useful to aid clinical decision-making to determine whether surgery or active surveillance strategy should be pursued.</description><subject>Original</subject><issn>2052-0034</issn><issn>2052-0034</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqFkcFu1DAQhiMEolXplSPyEQ7bjuM4zp4QqgpFquDSni3HmSRGcca1nVZ9DN6YbHepyomTLfvzNzP-i-I9hzMOW3E-mJQjnQ9kEGp4VRyXIMsNgKhev9gfFacp_QIADqqUXL4tjkSzVVWjmuPi9w_yNETjWU-RhYids9nNAwsmjzTR4Cyz5MOEGVnEFGhOuLLTRA9PWEQKGE1298jsiJ6i6RzlcT0Lj8zNO5HDOSf24PLIMFEYzYBmYuluMZ6WxCxOE7MmWjeTN--KN72ZEp4e1pPi9uvlzcXV5vrnt-8XX643VnDIm2proa5AQtdvq66VohRVj0q1reKK903fWdvKGhD6UoBVFQrVy1ryjsv1LxpxUnzee8PSeuzs2mM0kw7ReRMfNRmn_72Z3agHutecl6UStVwNHw-GSHcLpqy9S7thzIzrXFqAqlUtQe2Kne1RGymliP1zHQ56l6XeZ6kPWa4PPrzs7hn_m9wKfNoDtIT_yf4AO8Gwzg</recordid><startdate>20240706</startdate><enddate>20240706</enddate><creator>Shin, Young Seob</creator><creator>Jang, Jeong Yun</creator><creator>Yoo, Ye Jin</creator><creator>Yu, Jesang</creator><creator>Song, Kye Jin</creator><creator>Jo, Yoon Young</creator><creator>Kim, Sung-Bae</creator><creator>Park, Sook Ryun</creator><creator>Song, Ho June</creator><creator>Kim, Yong-Hee</creator><creator>Kim, Hyeong Ryul</creator><creator>Kim, Jong Hoon</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5544-9492</orcidid><orcidid>https://orcid.org/0000-0003-2177-4876</orcidid></search><sort><creationdate>20240706</creationdate><title>Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma</title><author>Shin, Young Seob ; Jang, Jeong Yun ; Yoo, Ye Jin ; Yu, Jesang ; Song, Kye Jin ; Jo, Yoon Young ; Kim, Sung-Bae ; Park, Sook Ryun ; Song, Ho June ; Kim, Yong-Hee ; Kim, Hyeong Ryul ; Kim, Jong Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Young Seob</creatorcontrib><creatorcontrib>Jang, Jeong Yun</creatorcontrib><creatorcontrib>Yoo, Ye Jin</creatorcontrib><creatorcontrib>Yu, Jesang</creatorcontrib><creatorcontrib>Song, Kye Jin</creatorcontrib><creatorcontrib>Jo, Yoon Young</creatorcontrib><creatorcontrib>Kim, Sung-Bae</creatorcontrib><creatorcontrib>Park, Sook Ryun</creatorcontrib><creatorcontrib>Song, Ho June</creatorcontrib><creatorcontrib>Kim, Yong-Hee</creatorcontrib><creatorcontrib>Kim, Hyeong Ryul</creatorcontrib><creatorcontrib>Kim, Jong Hoon</creatorcontrib><collection>Open Access: Oxford University Press Open Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gastroenterology report</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Young Seob</au><au>Jang, Jeong Yun</au><au>Yoo, Ye Jin</au><au>Yu, Jesang</au><au>Song, Kye Jin</au><au>Jo, Yoon Young</au><au>Kim, Sung-Bae</au><au>Park, Sook Ryun</au><au>Song, Ho June</au><au>Kim, Yong-Hee</au><au>Kim, Hyeong Ryul</au><au>Kim, Jong Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma</atitle><jtitle>Gastroenterology report</jtitle><addtitle>Gastroenterol Rep (Oxf)</addtitle><date>2024-07-06</date><risdate>2024</risdate><volume>12</volume><spage>goae060</spage><pages>goae060-</pages><issn>2052-0034</issn><eissn>2052-0034</eissn><abstract>Abstract Background In patients with esophageal squamous cell carcinoma (ESCC), accurately predicting a pathologic complete response (pCR) to preoperative chemoradiotherapy (PCRT) has the potential to enable an active surveillance strategy without esophagectomy. We aimed to establish a reliable multiparameter nomogram model that combines tumor characteristics, imaging modalities, and hematologic markers to predict pCR in patients with ESCC who underwent PCRT and esophagectomy. Methods We retrospectively reviewed the medical records of 457 patients with ESCC who received PCRT followed by esophagectomy between January 2005 and October 2020. The nomogram model was developed using logistic regression analysis with a training cohort and externally validated with a validation cohort. Results In the training and validation cohorts, 44.2% (126/285) and 48.3% (83/172) of patients, respectively, achieved pCR after PCRT. The 5-year rates of overall survival, progression-free survival, and freedom from local progression in the training cohort were 51.6%, 48.5%, and 77.6%, respectively. The parameters included in the nomogram were histologic grade, clinical N stage, maximum standardized uptake value on positron emission tomography, and post-PCRT biopsy. Hematologic markers were significantly associated with survival outcomes but not with pCR. The area under the receiver operating characteristic curve of the nomogram was 0.717, 0.704, and 0.707 for the training cohort, internal validation cohort, and external validation cohort, respectively. Conclusion Our nomogram model based on four parameters obtained from standard clinical practice demonstrated good performance in both the training and validation cohorts and could be useful to aid clinical decision-making to determine whether surgery or active surveillance strategy should be pursued.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>38974878</pmid><doi>10.1093/gastro/goae060</doi><orcidid>https://orcid.org/0000-0002-5544-9492</orcidid><orcidid>https://orcid.org/0000-0003-2177-4876</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2052-0034
ispartof Gastroenterology report, 2024-07, Vol.12, p.goae060
issn 2052-0034
2052-0034
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11227365
source Open Access: PubMed Central; Open Access: Oxford University Press Open Journals
subjects Original
title Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T23%3A19%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nomogram%20for%20predicting%20pathologic%20complete%20response%20following%20preoperative%20chemoradiotherapy%20in%20patients%20with%20esophageal%20squamous%20cell%20carcinoma&rft.jtitle=Gastroenterology%20report&rft.au=Shin,%20Young%20Seob&rft.date=2024-07-06&rft.volume=12&rft.spage=goae060&rft.pages=goae060-&rft.issn=2052-0034&rft.eissn=2052-0034&rft_id=info:doi/10.1093/gastro/goae060&rft_dat=%3Cproquest_pubme%3E3076765078%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c310t-49c064050df94db53234fe77bb7171f8fdccb560e0f230c74e37f5651d1500083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3076765078&rft_id=info:pmid/38974878&rft_oup_id=10.1093/gastro/goae060&rfr_iscdi=true